Table 1 Lp(a) levels at baseline and 1-month after LLT
Lipid-lowering strategy | Baseline (mg/dL) | On-statin (mg/dL) | percent change |
|---|---|---|---|
statin (n = 457) | 13.0 (8.0, 28.0) | 15.1 (8.3, 35.4) | +19.28% |
statin + ezetimibe (n = 31) | 14.0 (9.0, 22.0) | 14.4 (9.0, 28.0) | +19.56% |
Total (n = 488) | 13.0 (8.0, 27.0) | 15.1 (8.3, 35.1) | +19.30% |